Powers Advisory Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Powers Advisory Group's LLY Position: Q1 2026 in Review
Powers Advisory Group reduced its Eli Lilly (LLY) stake by 3.4% in Q1 2026, selling an estimated $79.1K and leaving 2,216 shares worth $2.04M. The position accounts for 0.72% of the portfolio, ranked #26.
Powers Advisory Group first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.47M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Powers Advisory Group held 2,216 shares of Eli Lilly worth $2.04M as of Q1 2026.
- Powers Advisory Group sold 78 Eli Lilly shares in Q1 2026, an estimated $79.1K.
- Eli Lilly made up 0.72% of Powers Advisory Group's portfolio in Q1 2026, its #26 holding.
- Powers Advisory Group first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
- Powers Advisory Group's Eli Lilly position peaked at $2.47M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Powers Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.